Name
and
Present
Position:
DAVID
M.
DORFMAN,
Staff
Pathologist
Address:
Brigham
and
Women's
Hospital,
Department
of
Pathology,
75
Francis
Street,
Boston,
MA
Medical
School
(including
school
name,
date
and
degree
awarded):
1986
MD,
University
of
Iowa,
Iowa
City,
IA
|
| |
Graduate
Medical Education (including dates and institution of internships, residencies,
fellowships, etc.):
1986 PhD, University
of Iowa
1986-88 Resident in Pathology, Brigham & Women's Hospital
1988-91 Research Fellow in Pediatrics, Children's Hospital, Boston,
MA
1991-92 Hematopathology Fellow, Brigham & Women's Hospital
1992-93 Resident in Pathology, Brigham & Women's Hospital
Certification:
1992 American Board
of Pathology (Anatomic and Clinical Pathology)
1996 American Board of Pathology (Hematology)
Current Academic
Appointment:
Associate Professor
of Pathology, Harvard Medical School, Boston, MA
Current Medical
Staff Appointment(s):
Associate
Director, Clinical Laboratories Division, Brigham and Women's Hospital
Medical Director, Hematology Laboratory, Brigham and Women's Hospital
Pathologist, Brigham and Women's Hospital
Selected Bibliography:
- Weng
AP, Shahsafaei A, Dorfman DM. CXCR4/CD184 immunoreactivity in T cell
non-Hodgkin’s lymphomas with an overall Th1(-) Th2(+) immunophenotype.
Am J Clin Pathol 2003; 119:424-430.
- Dorfman
DM, Greisman HA, Shahsafaei A. Loss of expression of the WNT/beta-catenin
signaling pathway transcription factors LEF-1 and TCF-1 in a subset
of peripheral T cell lymphomas. Am J Pathol 2003; 1539-1544.
-
Dorfman D.M., van den Elzen P., Weng A.P., Shahsafaei A., Glimcher L.H.
Differential expression of T-bet, a T box transcription factor required
for Th1 T cell development, in peripheral T cell lymphomas. Am J Clin
Pathol 2003; 120:866-873.
-
Dorfman DM, Hwang ES, Shahsafaei A, Glimcher LH. T cell-associated transcription
factor T-bet is expressed in Hodgkin lymphoma. Human Pathology 2005;
36:10-15.
-
Rodig SR, Shahsafaei A, Li B, Dorfman DM. The CD45 isoform B220 serves
to identify a select subset of human B cells and B cell lymphoproliferative
disorders. Human Pathology 2005; 36:51-57.
|
